|
|
|
|
LEADER |
03688nam a2200733 4500 |
001 |
ocn841170430 |
003 |
OCoLC |
005 |
20170124071257.7 |
006 |
m o d |
007 |
cr cn||||||||a |
008 |
130403s2013 gw a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d OCLCO
|d DG1
|d CUS
|d N$T
|d YDXCP
|d OCLCA
|d NOC
|d OCLCQ
|d OCLCO
|d OCLCF
|d OCLCQ
|d EBLCP
|d IDEBK
|d COO
|d CDX
|d DKDLA
|d GrThAP
|
019 |
|
|
|a 833767002
|a 857445483
|a 898059839
|a 961570576
|a 962651666
|
020 |
|
|
|a 9783527670383
|q (electronic bk.)
|
020 |
|
|
|a 3527670386
|q (electronic bk.)
|
020 |
|
|
|a 9783527670390
|q (electronic bk.)
|
020 |
|
|
|a 3527670394
|q (electronic bk.)
|
020 |
|
|
|z 9783527332557
|
020 |
|
|
|a 3527332553
|
020 |
|
|
|a 9783527332557
|
020 |
|
|
|a 9781299402201
|
020 |
|
|
|a 1299402208
|
029 |
1 |
|
|a AU@
|b 000051628951
|
029 |
1 |
|
|a CHBIS
|b 010026926
|
029 |
1 |
|
|a CHVBK
|b 306240947
|
029 |
1 |
|
|a DEBBG
|b BV042795223
|
029 |
1 |
|
|a NZ1
|b 15340141
|
029 |
1 |
|
|a DEBBG
|b BV043395769
|
029 |
1 |
|
|a AU@
|b 000053034676
|
029 |
1 |
|
|a DKDLA
|b 820120-katalog:000651630
|
035 |
|
|
|a (OCoLC)841170430
|z (OCoLC)833767002
|z (OCoLC)857445483
|z (OCoLC)898059839
|z (OCoLC)961570576
|z (OCoLC)962651666
|
037 |
|
|
|a 471470
|b MIL
|
050 |
|
4 |
|a RC119
|b .T79 2013eb
|
072 |
|
7 |
|a MED
|x 103000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.9/6
|2 23
|
049 |
|
|
|a MAIN
|
245 |
0 |
0 |
|a Trypanosomatid diseases :
|b molecular routes to drug discovery /
|c edited by Timo Jäger, Oliver Koch, and Leopold Flohé.
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a Weinheim :
|b Wiley-VCH,
|c 2013.
|
300 |
|
|
|a 1 online resource (xxviii, 547 pages) :
|b illustrations (some color).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Drug discovery in infectious diseases ;
|v v. 4
|
500 |
|
|
|a Edition statement from running title area.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a pt. 1. Disease burden, current treatments, medical needs, and strategic approaches -- pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery -- pt. 3. Validation and selection of drug targets in kinetoplasts -- pt. 4. Examples of target-based approaches and compounds under consideration.
|
588 |
0 |
|
|a Online resource; title from PDF title page (Wiley, viewed May 28, 2013).
|
520 |
|
|
|a This is the first resource to provide researchers in academia and industry with an urgently needed update summarizing the current knowledge and possibilities for drug intervention against Trypanosomatides all in one volume. As such, it covers every aspect of the topic from basic research findings, via current treatments to translational approaches in drug development and includes both human and livestock diseases. The outstanding editor and contributor team reads like a Who?s Who of the field, thus guaranteeing the outstanding quality of this ready reference.
|
650 |
|
0 |
|a Parasitic diseases.
|
650 |
|
0 |
|a Trypanosomatidae.
|
650 |
|
7 |
|a MEDICAL
|x Parasitology.
|2 bisacsh
|
650 |
|
7 |
|a Parasitic diseases.
|2 fast
|0 (OCoLC)fst01053151
|
650 |
|
7 |
|a Trypanosomatidae.
|2 fast
|0 (OCoLC)fst01158279
|
650 |
|
4 |
|a Trypanosomiasis
|x Chemotherapy.
|
650 |
|
4 |
|a Trypanosomiasis.
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Jäger, Timo.
|
700 |
1 |
|
|a Koch, Oliver.
|
700 |
1 |
|
|a Flohé, L.
|q (Leopold),
|d 1938-
|
776 |
0 |
8 |
|i Print version:
|t Trypanosomatid diseases.
|d Weinheim, Germany : Wiley-Blackwell, [2013]
|z 9783527332557
|w (OCoLC)843345756
|
830 |
|
0 |
|a Drug discovery in infectious diseases ;
|v v. 4.
|
856 |
4 |
0 |
|u https://doi.org/10.1002/9783527670383
|z Full Text via HEAL-Link
|
994 |
|
|
|a 92
|b DG1
|